<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A human <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) cell line, BALM-27, was established from the peripheral blood specimen of a patient with B-cell ALL L3 type (ALL-L3) at diagnosis </plain></SENT>
<SENT sid="1" pm="."><plain>As with the original <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells, the established line was negative for <z:hpo ids='HP_0000001'>all</z:hpo> cell surface immunoglobulin (Ig) chains, but carrying only cytoplasmic Ig delta heavy chain </plain></SENT>
<SENT sid="2" pm="."><plain>Southern blot analysis of the various Ig chain genes demonstrated homozygous deletion of the Jkappa gene, germ line configuration of the Jlambda and rearrangement of IgJH genes </plain></SENT>
<SENT sid="3" pm="."><plain>Cytogenetic analysis of both primary leukemic bone marrow and BALM-27 cells showed the der(8;15)(q10;q10) chromosomal alteration, in addition to the t(8;22)(q24;q11) abnormality which is highly associated with ALL-L3 and Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The established cell line BALM-27 represents a rich resource of abundant, accessible, and manipulable cell material for analyzing the unique expression of Ig chain and for investigating the pathogenesis of B-cell <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The scientific significance of BALM-27 lies in (1) the rarity of this type of <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell lines, and (2) its unique chromosomal aberrations </plain></SENT>
</text></document>